e-space
Manchester Metropolitan University's Research Repository

    Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages

    Howe, RA, Monk, A, Wootton, M, Walsh, TR and Enright, Mark (2004) Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages. Emerging Infectious Diseases, 10 (5). pp. 855-857. ISSN 1080-6040

    [img]
    Preview
    Published Version
    Available under License Creative Commons Attribution.

    Download (47kB) | Preview

    Abstract

    Methicillin-resistant Staphylococcus aureus (MRSA) with reduced vancomycin susceptibility vancomycin-intermediate S. aureus (VISA) has been reported from many countries. Whether resistance is evolving regularly in different genetic backgrounds or in a single clone with a genetic predisposition, as early results suggest, is unclear. We have studied 101 MRSA with reduced vancomycin susceptibility from nine countries by multilocus sequence typing (MLST), characterization of SCCmec (staphylococcal chromosomal cassette mec), and agr (accessory gene regulator). We found nine genotypes by MLST, with isolates within all five major hospital MRSA lineages. Most isolates (88/101) belonged to two of the earliest MRSA clones that have global prevalence. Our results show that reduced susceptibility to vancomycin has emerged in many successful epidemic lineages with no clear clonal disposition. Increasing antimicrobial resistance in genetically distinct pandemic clones may lead to MRSA infections that will become increasingly difficult to treat.

    Impact and Reach

    Statistics

    Activity Overview
    6 month trend
    203Downloads
    6 month trend
    280Hits

    Additional statistics for this dataset are available via IRStats2.

    Altmetric

    Repository staff only

    Edit record Edit record